155 related articles for article (PubMed ID: 36607486)
1. Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study.
Meernik C; Jorgensen K; Wu CF; Murphy CC; Baker VL; Brady PC; Nitecki R; Nichols HB; Rauh-Hain JA
Breast Cancer Res Treat; 2023 Feb; 198(1):149-158. PubMed ID: 36607486
[TBL] [Abstract][Full Text] [Related]
2. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
3. Residential proximity to a fertility clinic is independently associated with likelihood of women having ART and IUI treatment.
Lazzari E; Baffour B; Chambers GM
Hum Reprod; 2022 Oct; 37(11):2662-2671. PubMed ID: 36112009
[TBL] [Abstract][Full Text] [Related]
4. Disparities in fertility preservation use among adolescent and young adult women with cancer.
Meernik C; Engel SM; Wardell A; Baggett CD; Gupta P; Rodriguez-Ormaza N; Luke B; Baker VL; Wantman E; Rauh-Hain JA; Mersereau JE; Olshan AF; Smitherman AB; Cai J; Nichols HB
J Cancer Surviv; 2023 Oct; 17(5):1435-1444. PubMed ID: 35169982
[TBL] [Abstract][Full Text] [Related]
5. Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer.
Kanbergs A; Jorgensen K; Agusti N; Viveros-Carreño D; Wu CF; Nitecki R; Harris JA; Woodard T; Ramphul R; Rauh-Hain JA
Obstet Gynecol; 2024 Jun; 143(6):824-834. PubMed ID: 38574368
[TBL] [Abstract][Full Text] [Related]
6. Effect of state insurance mandates on racial/ethnic disparities in the utilization and outcomes of donor oocyte-assisted reproductive technologies.
Liao C; Kotlyar AM; Seifer DB
Fertil Steril; 2023 Jul; 120(1):111-122. PubMed ID: 36871857
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study.
Rauh-Hain JA; Zubizarreta J; Nitecki R; Melamed A; Fu S; Jorgensen K; Brady PC; Baker VL; Chavez-MacGregor M; Giordano SH; Keating NL
Cancer; 2022 Sep; 128(17):3243-3253. PubMed ID: 35767282
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Fertility-Sparing Treatment and Use of Assisted Reproductive Technology After a Diagnosis of Cervical, Ovarian, or Endometrial Cancer.
Jorgensen K; Meernik C; Wu CF; Murphy CC; Baker VL; Jarmon P; Brady PC; Nitecki R; Nichols HB; Rauh-Hain JA
Obstet Gynecol; 2023 Feb; 141(2):341-353. PubMed ID: 36649345
[TBL] [Abstract][Full Text] [Related]
9. The risks of birth defects and childhood cancer with conception by assisted reproductive technology.
Luke B; Brown MB; Wantman E; Schymura MJ; Browne ML; Fisher SC; Forestieri NE; Rao C; Nichols HB; Yazdy MM; Gershman ST; Sacha CR; Williams M; Ethen MK; Canfield MA; Doody KJ; Eisenberg ML; Baker VL; Williams C; Sutcliffe AG; Richard MA; Lupo PJ
Hum Reprod; 2022 Oct; 37(11):2672-2689. PubMed ID: 36112004
[TBL] [Abstract][Full Text] [Related]
10. Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction.
Crawford S; Joshi N; Boulet SL; Bailey MA; Hood ME; Manning SE; McKane P; Kirby RS; Kissin DM; Jamieson DJ;
Obstet Gynecol; 2017 Jun; 129(6):1022-1030. PubMed ID: 28486370
[TBL] [Abstract][Full Text] [Related]
11. Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study.
Machtinger R; Fallach N; Goldstein I; Chodick G; Schiff E; Orvieto R; Mashiach R
Hum Reprod; 2022 Mar; 37(3):577-585. PubMed ID: 34871410
[TBL] [Abstract][Full Text] [Related]
12. Assisted Reproductive Technology Surveillance — United States, 2012.
Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
MMWR Surveill Summ; 2015 Aug; 64(6):1-29. PubMed ID: 26270152
[TBL] [Abstract][Full Text] [Related]
13. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis.
Arecco L; Blondeaux E; Bruzzone M; Ceppi M; Latocca MM; Marrocco C; Boutros A; Spagnolo F; Razeti MG; Favero D; Spinaci S; Condorelli M; Massarotti C; Goldrat O; Del Mastro L; Demeestere I; Lambertini M
Hum Reprod; 2022 May; 37(5):954-968. PubMed ID: 35220429
[TBL] [Abstract][Full Text] [Related]
14. Population-wide contribution of medically assisted reproductive technologies to overall births in Australia: temporal trends and parental characteristics.
Choi SKY; Venetis C; Ledger W; Havard A; Harris K; Norman RJ; Jorm LR; Chambers GM
Hum Reprod; 2022 May; 37(5):1047-1058. PubMed ID: 35220435
[TBL] [Abstract][Full Text] [Related]
15. Assisted reproductive technology treatment and risk of breast cancer: a population-based cohort study.
Vassard D; Pinborg A; Kamper-Jørgensen M; Lyng Forman J; Glazer CH; Kroman N; Schmidt L
Hum Reprod; 2021 Nov; 36(12):3152-3160. PubMed ID: 34580714
[TBL] [Abstract][Full Text] [Related]
16. Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
Tait SD; Ren Y; Horton CC; Oshima SM; Thomas SM; Wright S; Caesar A; Plichta JK; Hwang ES; Greenup RA; Rosenberger LH; DiLalla GD; Menendez CS; Tolnitch L; Hyslop T; Nelson D; Fayanju OM
Cancer; 2021 Jul; 127(14):2515-2524. PubMed ID: 33826758
[TBL] [Abstract][Full Text] [Related]
17. Assisted reproductive technology surveillance--United States, 2011.
Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Barfield WD;
MMWR Surveill Summ; 2014 Nov; 63(10):1-28. PubMed ID: 25412164
[TBL] [Abstract][Full Text] [Related]
18. Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature.
Carneiro MM; Cota AM; Amaral MC; Pedrosa ML; Martins BO; Furtado MH; Lamaita RM; Ferreira MCF
JBRA Assist Reprod; 2018 Sep; 22(3):244-252. PubMed ID: 29932615
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after assisted reproductive technology in women with cancer: a systematic review and meta-analysis.
Meernik C; Poole C; Engel SM; Rauh-Hain JA; Luke B; Nichols HB
Hum Reprod; 2023 Jan; 38(1):30-45. PubMed ID: 36342891
[TBL] [Abstract][Full Text] [Related]
20. Disparities in Viral Suppression and Medication Adherence among Women in the USA, 2011-2016.
Geter A; Sutton MY; Armon C; Buchacz K;
AIDS Behav; 2019 Nov; 23(11):3015-3023. PubMed ID: 30968277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
